Yasmin


What it is used for

INDICATIONS: Yasmin is indicated for use as an oral contraceptive.


How to take it

This medicine is a pack that contains more than one part.

Part 1: Tablet, film coated

Light yellow, round and biconvex film-coated tablet with ‘DO’ embossed on one side in a regular hexagon

The way to take this medicine is: Oral. This medicine is taken by mouth.

Part 2: Tablet, film coated

Small, round white tablet

The way to take this medicine is: Oral. This medicine is taken by mouth.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems


How to take it

This medicine is a pack that contains more than one part.

Part 1: Tablet, film coated

Light yellow, round and biconvex film-coated tablet with ‘DO’ embossed on one side in a regular hexagon

The way to take this medicine is: Oral. This medicine is taken by mouth.

Part 2: Tablet, film coated

Small, round white tablet

The way to take this medicine is: Oral. This medicine is taken by mouth.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Pregnant or planning a pregnancy?

For the active ingredient drospirenone + ethinylestradiol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.


Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.


Visual appearance

Images are the copyright of the Pharmacy Guild of Australia

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments